Compare · EBAC vs PNTM
EBAC vs PNTM
Side-by-side comparison of European Biotech Acquisition Corp. (EBAC) and Pontem Corporation (PNTM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both EBAC and PNTM operate in Blank Checks (Finance), so they compete in similar markets.
- PNTM is the larger of the two at $838.8M, about 5.2x EBAC ($160.7M).
European Biotech Acquisition Corp.
European Biotech Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Amsterdam, the Netherlands.
Pontem Corporation
Pontem Corporation does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Latest EBAC
- SEC Form 15-12G filed by European Biotech Acquisition Corp.
- SEC Form 25-NSE/A filed by European Biotech Acquisition Corp. (Amendment)
- European Biotech Acquisition Corp. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
- SEC Form 10-K filed by European Biotech Acquisition Corp.
- European Biotech Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form DEFA14A filed by European Biotech Acquisition Corp.
- SEC Form SC 13G filed by European Biotech Acquisition Corp.
- European Biotech Acquisition Corp. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- SEC Form SC 13G filed by European Biotech Acquisition Corp.
- SEC Form SC 13G/A filed by European Biotech Acquisition Corp. (Amendment)
Latest PNTM
- SEC Form SC 13G filed by Pontem Corporation
- SEC Form SC 13G/A filed by Pontem Corporation (Amendment)
- SEC Form 15-12G filed by Pontem Corporation
- SEC Form 25-NSE filed by Pontem Corporation
- Pontem Corporation Will Redeem Its Public Shares And Will Not Consummate An Initial Business Combination; Redemption Price For The Public Shares Will Be ~$10.32
- Pontem Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Pontem Corporation will redeem its Public Shares and will not consummate an initial business combination
- SEC Form 10-Q filed by Pontem Corporation
- SEC Form 3 filed by new insider Hagen David
- Pontem Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits